港股異動 | 香港電視高開6.84% 2月平均每日訂單總商品交易額增長159.4%
格隆匯3月4日丨香港電視(1137.HK)高開6.84%,報4.84港元,暫成交366萬港元,最新總市值44億港元。香港電視昨晚發公告稱,今年2月,集團網購平台及門市業務平均每日訂單總商品交易額(調整至最接近的十萬位數)同比增長159.4%至1660萬港元;每月訂單總商品交易額(調整至最接近的百萬位數)同比增長169.3%至4.82億港元。公告表示,在新型冠狀病毒疫情下,香港市民留在家中時間增加且對前往人多擠迫地點的意欲減弱,令集團於2月的業務增長動力持續。集團預期在經過幾個月的網購體驗後,部份客户可能會將購物行為由線下轉為線上。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.